DRMA · Dermata Therapeutics, Inc. · Investor Relations
$1.11
+0.01 (+0.45%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the financial statements, which is not alleviated by management's plans.”View the 10-Q filed Aug 11, 2026
Market Cap
$4.58M
Shares
4.02M
Volume · Oct 5
14.16K
Avg daily vol (3M)
710.93K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-05-27 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
Source: https://ir.dermatarx.com/